Similar to the findings observed in MS non-responders to IFNb, hepatitis C non-responders present higher levels of type I IFN responsive genes such as MX1, OAS1 and STAT1 before treatment initiation [6]. The gene discussed is IFNB1; the disease is myeloid sarcoma.